iTeos Therapeutics, Inc. (ITOS)

10.15

+0.02 (0.20%)

Inactive · Last trade price on Aug 28, 2025

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cancer Immunotherapies	35.00M	Log In	Log In	Log In
Cancer Immunotherapies Growth	177.89%	Log In	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Belgium	35.00M	Log In	Log In	Log In
United States and Belgium	-	Log In	Log In	Log In
United States and Belgium Growth	-	Log In	Log In	Log In